Serum-Free Light Chain Surge Linked to Tumor Lysis Syndrome in Myeloma
A sudden increase of serum-free light chains was associated with treatment-induced tumor lysis syndrome in multiple myeloma, suggesting a possible risk factor.
Multiple Myeloma
Analysis Determines Cost Effectiveness of Various Treatment Strategies for Multiple Myeloma
In this systematic review, researchers analyzed the cost effectiveness of various treatments and treatment lines for multiple myeloma.
Dental Issues Can Delay Treatment for Patients With Multiple Myeloma
A case series study demonstrated the importance of timely, preventive dental assessment for patients with multiple myeloma.
Care at High-Volume Facility May Cut Mortality in Multiple Myeloma
Mortality did not differ for those treated by NCICCC MM specialists, highest-volume community oncologists.
Strategies for Increasing PRO Response Rates in Patients With Multiple Myeloma
An analysis of completion rates for PRO measures among patients with multiple myeloma found that reminders and use of preferred delivery mode influence response rate.
Mechanism Unearthed for Carfilzomib-Induced Reticulocytosis in Myeloma
Irreversible proteasome inhibitor carfilzomib appears to cause reticulocytosis in multiple myeloma by inhibiting terminal erythroid maturation.
Real-World Insight on Patients With Multiple Myeloma: Results Drawn From a Large Health Plan
A retrospective cohort study identified real-world epidemiology, treatment patterns, and survival outcomes in patients with multiple myeloma in Israel.
Nelfinavir Plus Lenalidomide, Dexamethasone Improves Response in Lenalidomide-Refractory Multiple Myeloma
Results of a phase 1/2 trial demonstrated the efficacy of nelfinavir in combination with lenalidomide and dexamethasone for lenalidomide-refractory MM.
Analysis of Cardiovascular Disease Risks With Different Types of Cancer
Population-based cohort study demonstrated associations between many site-specific cancers and the development of CVDs.
Patient Preferences Explored in Multiple Myeloma Treatment
All-oral regimen linked to higher satisfaction with treatment convenience in relapsed, refractory multiple myeloma.
Next post in Multiple Myeloma
